Taisho Pharmaceutical has entered into a strategic partnership with AC Health, one of the Philippines' leading healthcare organizations, to expand access to high-quality healthcare solutions and support better health outcomes for Filipino communities.

As Japan's largest pharmaceutical company and the leading Japanese pharmaceutical company operating in the Philippines, Taisho has a long-standing commitment to delivering trusted, innovative healthcare products backed by Japanese quality and expertise. Through this partnership, Taisho further strengthens its efforts to make quality medicines and healthcare solutions more accessible to Filipinos nationwide.

The collaboration brings together Taisho's portfolio of trusted pharmaceutical and healthcare products with AC Health's extensive healthcare ecosystem, strong market presence, and deep understanding of local healthcare needs. By leveraging their complementary strengths, the two organizations aim to broaden access to innovative healthcare solutions and create greater value for patients, consumers, and healthcare providers across the country.

The partnership reflects Taisho's continued confidence in the Philippine market and its commitment to supporting the country's evolving healthcare needs. It also underscores the shared vision of Taisho and AC Health to improve healthcare accessibility and help more Filipinos live healthier, better lives through world-class healthcare products, services, and innovations.